Isukuba, Japan

Hiroshi Kushida

This inventor holds 1 USPTO granted patent. Top assignee: Banyu Pharmaceutical Co. Ltd. Active years: 1999.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Hiroshi Kushida. Retrieved from https://idiyas.com/inventor/hiroshi-kushida-eetqtsm8

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 7.0

ph-index = 1


Company Filing History:


Years Active: 1999

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Hiroshi Kushida: Innovator in Antifungal Substances

Introduction

Hiroshi Kushida is a notable inventor based in Isukuba, Japan. He has made significant contributions to the field of pharmaceuticals, particularly in the development of antifungal substances. His work has implications for medical treatments and the pharmaceutical industry.

Latest Patents

Hiroshi Kushida holds a patent for antifungal substances known as BE-49385, along with the process for their production. This innovation represents a step forward in the fight against fungal infections, showcasing his expertise and dedication to improving health outcomes.

Career Highlights

Kushida is associated with Banyu Pharmaceutical Co. Ltd., where he has been instrumental in research and development. His career reflects a commitment to advancing pharmaceutical science and addressing critical health challenges.

Collaborations

Throughout his career, Kushida has collaborated with esteemed colleagues, including Shigeru Nakajima and Shigeru Uchiyama. These partnerships have fostered innovation and contributed to the success of his projects.

Conclusion

Hiroshi Kushida's work in developing antifungal substances highlights his role as a key inventor in the pharmaceutical industry. His contributions continue to impact medical science and improve treatment options for patients.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…